Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3132 is an intronic microRNA transcribed as part of the human TMEM198 gene. It is a small non-coding RNA (about 18-22 nucleotides) whose main function is to regulate gene expression post-transcriptionally by binding to 3’ untranslated regions of mRNAs. Recent research shows that miR-3132 is downregulated in a wide range of cancer cell lines and that re-introduction (via synthetic miRNA mimics) potently suppresses cancer cell proliferation and induces apoptosis, particularly through upregulation of the pro-apoptotic ligand TRAIL and activation of Type I interferon/JAK-STAT signaling. This apoptosis is independent of p53 status and relies on extrinsic pathway markers. The therapeutic concept of miR-3132 is under pre-clinical investigation as a novel approach to cancer treatment.
miRNA mimics: Direct replacement of suppressed miR-3132, restoring its function in cancer cells. Induction of cell-surface TRAIL and activation of extrinsic apoptotic pathway. Upregulation of interferon and JAK-STAT signaling resulting in transcriptional activation of TRAIL and apoptosis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3132 (MIR3132).